orfadin suspension
swedish orphan biovitrum ab (publ) - nitisinone - suspension - 4mg - nitisinone 4mg - other miscellaneous therapeutic agents
empaveli solution
swedish orphan biovitrum ab (publ) - pegcetacoplan - solution - 1080mg - pegcetacoplan 1080mg
optzuro
truemed ltd, israel - avatrombopag as maleate - film coated tablets - avatrombopag as maleate 20 mg - avatrombopag - for the treatment of severe thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo an invasive procedure.for the treatment of primary chronic immune thrombocytopenia (itp) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins)
kepivance
a menarini australia pty ltd - palifermin -
day & night cold & flu + cough capsule, combination
johnson & johnson pacific pty ltd - chlorphenamine maleate,dextromethorphan hydrobromide monohydrate,paracetamol,phenylephrine hydrochloride -
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinuria, paroxysmal - immunosuppressants - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
orfadin 2 mg hard capsules
megapharm ltd - nitisinone - hard capsule - nitisinone 2 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון once daily
orfadin 5 mg hard capsules
megapharm ltd - nitisinone - hard capsule - nitisinone 5 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון once daily
orfadin 10 mg hard capsules
megapharm ltd - nitisinone - hard capsule - nitisinone 10 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine05/06/2018 בקשה לשינוי משטר מינון once daily
kineret 100 mg solution for injection
megapharm ltd - anakinra - solution for injection - anakinra 150 mg/ml - anakinra - anakinra - kineret 100 mg solution for injection is indicated in adults for the treatment of the signs and symptoms of rheumatoid arthritis (ra) in combination with methotrexate, in patients with an inadequate response to methotrexate alone.kineret 100 mg solution for injection is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of cryopyrin-associated periodic syndromes (caps), including:- neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)- muckle-wells syndrome (mws)- familial cold autoinflammatory syndrome (fcas) kineret 100 mg solution for injection is indicated for the treatment of familial mediterranean fever (fmf). kineret 100 mg solution for injection should be given in combination with colchicine, if appropriate.